Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)

Fei Wang, Li Yang, Qun Gao, Lan Huang, Liping Wang, Jing Wang, Shengdian Wang, Bin Zhang, Yi Zhang*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Abstract

The paper “CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (PMID: 25944005)” was published in Cancer Immunol Immunother at August 2015 online. After carefully re-checking the original files, we noticed that two issues should be explained and corrected as below.

Original languageEnglish (US)
Pages (from-to)3057-3059
Number of pages3
JournalCancer Immunology, Immunotherapy
Volume70
Issue number10
DOIs
StatePublished - Oct 2021

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'Correction to: CD163+CD14+ macrophages, a potential immune biomarker for malignant pleural effusion (Cancer Immunology, Immunotherapy, (2015), 64, 8, (965-976), 10.1007/s00262-015-1701-9)'. Together they form a unique fingerprint.

Cite this